256 related articles for article (PubMed ID: 26732226)
1. [Hypersexuality and other impulse control disorders in Parkinson's disease].
Nelis EA; Berendse HW; van den Heuvel OA
Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
Nakum S; Cavanna AE
Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
[TBL] [Abstract][Full Text] [Related]
3. Hypersexuality and compulsive over-eating associated with transdermal dopamine agonist therapy.
Hinnell C; Hulse N; Martin A; Samuel M
Parkinsonism Relat Disord; 2011 May; 17(4):295-6. PubMed ID: 21300562
[No Abstract] [Full Text] [Related]
4. [Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].
Grandgenevre P; Warembourg F; Carrière N; Vaillant A; Defebvre L; Vaiva G
Presse Med; 2015 Mar; 44(3):e51-8. PubMed ID: 25578547
[TBL] [Abstract][Full Text] [Related]
5. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
[TBL] [Abstract][Full Text] [Related]
6. Impulse control disorders in Parkinson's disease.
Marques A; Durif F; Fernagut PO
J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
[TBL] [Abstract][Full Text] [Related]
7. The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
Claassen DO; van den Wildenberg WPM; Ridderinkhof KR; Jessup CK; Harrison MB; Wooten GF; Wylie SA
Behav Neurosci; 2011 Aug; 125(4):492-500. PubMed ID: 21604834
[TBL] [Abstract][Full Text] [Related]
8. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
[TBL] [Abstract][Full Text] [Related]
10. [Impulsive-compulsive syndrome in Parkinson's disease].
Nikitina AV; Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
[TBL] [Abstract][Full Text] [Related]
11. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
13. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
[TBL] [Abstract][Full Text] [Related]
14. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric Traits Associated with Refractory Impulse Control Disorder in Parkinson's Disease.
Choi JH; Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho JW
Neurodegener Dis; 2019; 19(5-6):171-177. PubMed ID: 32454490
[TBL] [Abstract][Full Text] [Related]
16. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
Bienfait KL; Menza M; Mark MH; Dobkin RD
J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
[TBL] [Abstract][Full Text] [Related]
17. Impulse control disorders in Parkinson's disease.
Weintraub D; Potenza MN
Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced impulse control disorders: a review.
Atmaca M
Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002
[TBL] [Abstract][Full Text] [Related]
19. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
Politis M; Loane C; Wu K; O'Sullivan SS; Woodhead Z; Kiferle L; Lawrence AD; Lees AJ; Piccini P
Brain; 2013 Feb; 136(Pt 2):400-11. PubMed ID: 23378222
[TBL] [Abstract][Full Text] [Related]
20. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
